Corporate Member Update: Boehringer Ingelheim, Inc.-

Corporate Member Update: Boehringer Ingelheim, Inc.-

treatments in squamous NSCLC
April, 2021

Boehringer Ingelheim invites the Nebraska Oncology Society members to the following event:

What Can We Learn About the Evolving Squamous NSCLC Treatment Landscape?
An Expert Discussion on Emerging Real-World Evidence

Click on the link for more information.

 
 
Become a NOS Member Today!
Join Now
 

Platinum Corporate Members

Gold Corporate Members